ResMed Inc. (NYSE:RMD) Q2 2026 Earnings Call Transcript January 29, 2026
ResMed Inc. beats earnings expectations. Reported EPS is $2.81, expectations were $2.74.
Operator: Greetings, and welcome to the ResMed Second Quarter Fiscal Year 2026 Earnings Conference Call. [Operator Instructions]. As a reminder, this conference is being recorded. It’s now my pleasure to turn the call over to Salli Schwartz, Chief Investor Relations Officer. Please go ahead.
Sallilyn Schwartz: Thanks, Kevin. I want...
